ISPE 2026: Real-world treatment patterns for trigeminal neuralgia: Evidence from a large EHR cohort

Authors: Mantas Dmukauskas , PhD ⊕, Truveta, Inc, Bellevue, WA, Puja Rao, MPH ⊕, Truveta, Inc , Bellevue, WA, Amy Sullivan, MS ⊕, Truveta, Inc, Bellevue, WA, Joud Rafael, MPH ⊕, Truveta, Inc, Bellevue, WA, Jared Kearn ⊕, Truveta, Inc, Bellevue, WA, Nadia Tabatabaeepour , MPH ⊕ Truveta, Inc, Bellevue, WA , Vidya Venkataraman , PhD ⊕ Truveta, Inc , Bellevue, WA, Sarah Eng, MPH ⊕, Truveta, Inc, Bellevue, WA, Amy Wu ⊕, Truveta, Inc, Bellevue, WA, Esther Kim, PhD ⊕ Truveta, Inc, Bellevue, WA, Fewer than one-third of patients with trigeminal neuralgia (TN) received guideline-recommended first-line t